EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,600 | -5.2% | 22,000 | 0.0% | 0.04% | +11.8% |
| Q2 2023 | $181,060 | +13.5% | 22,000 | 0.0% | 0.03% | +6.2% |
| Q1 2023 | $159,500 | -18.3% | 22,000 | 0.0% | 0.03% | -22.0% |
| Q4 2022 | $195,140 | -27.5% | 22,000 | 0.0% | 0.04% | -28.1% |
| Q3 2022 | $269,000 | +3.5% | 22,000 | 0.0% | 0.06% | +9.6% |
| Q2 2022 | $260,000 | -34.8% | 22,000 | +4.8% | 0.05% | -20.0% |
| Q1 2022 | $399,000 | -23.9% | 21,000 | +6.3% | 0.06% | -19.8% |
| Q4 2021 | $524,000 | -35.4% | 19,750 | 0.0% | 0.08% | -40.0% |
| Q3 2021 | $811,000 | -32.0% | 19,750 | -6.2% | 0.14% | -34.8% |
| Q2 2021 | $1,192,000 | +43.6% | 21,050 | +6.6% | 0.21% | +26.2% |
| Q1 2021 | $830,000 | -40.1% | 19,750 | 0.0% | 0.16% | -43.4% |
| Q4 2020 | $1,385,000 | +150.0% | 19,750 | 0.0% | 0.29% | +128.3% |
| Q3 2020 | $554,000 | -9.0% | 19,750 | 0.0% | 0.13% | -11.2% |
| Q2 2020 | $609,000 | +55.4% | 19,750 | 0.0% | 0.14% | +27.7% |
| Q1 2020 | $392,000 | – | 19,750 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |